Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laser Diagnostic Technologies (LDT) was a medical technology company specializing in the development and commercialization of advanced diagnostic tools for ophthalmology. The company is best known for its GDx Nerve Fiber Analyzer, which utilizes scanning laser polarimetry to measure the thickness of the retinal nerve fiber layer. This technology provided clinicians with a non-invasive method for the early detection and monitoring of glaucoma by identifying structural changes before vision loss occurs. LDT's innovations significantly advanced the field of ophthalmic imaging and established a new standard for glaucoma management. The company was acquired by Carl Zeiss Meditec in 2004, and its technology was integrated into the Zeiss diagnostic portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laser Diagnostic Technologies.